These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 9972340)

  • 21. Latanoprost, a prostaglandin analog, for glaucoma therapy. Efficacy and safety after 1 year of treatment in 198 patients. Latanoprost Study Groups.
    Camras CB; Alm A; Watson P; Stjernschantz J
    Ophthalmology; 1996 Nov; 103(11):1916-24. PubMed ID: 8942890
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The use of latanoprost 0.005% once daily to simplify medical therapy in patients with primary open-angle glaucoma or ocular hypertension.
    Smith SL; Pruitt CA; Sine CS; Hudgins AC; Stewart WC
    Acta Ophthalmol Scand; 1999 Apr; 77(2):189-92. PubMed ID: 10321536
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Latanoprost 0.005% in POAG: effects on IOP and ocular blood flow.
    Vetrugno M; Cantatore F; Gigante G; Cardia L
    Acta Ophthalmol Scand Suppl; 1998; (227):40-1. PubMed ID: 9972341
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comparative study of the effects of timolol and latanoprost on blood flow velocity of the retrobulbar vessels.
    Nicolela MT; Buckley AR; Walman BE; Drance SM
    Am J Ophthalmol; 1996 Dec; 122(6):784-9. PubMed ID: 8956632
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Randomized, Controlled, Phase 3 Trials of Carteolol/Latanoprost Fixed Combination in Primary Open-Angle Glaucoma or Ocular Hypertension.
    Yamamoto T; Ikegami T; Ishikawa Y; Kikuchi S;
    Am J Ophthalmol; 2016 Nov; 171():35-46. PubMed ID: 27565224
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Latanoprost. Two years' experience of its use in the United Kingdom. Latanoprost Study Group.
    Watson PG
    Ophthalmology; 1998 Jan; 105(1):82-7. PubMed ID: 9442782
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical experience with latanoprost: a retrospective study of 153 patients.
    Martin L
    Acta Ophthalmol Scand; 1999 Jun; 77(3):336-9. PubMed ID: 10406157
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A 12 week study comparing the fixed combination of latanoprost and timolol with the concomitant use of the individual components in patients with open angle glaucoma and ocular hypertension.
    Diestelhorst M; Larsson LI;
    Br J Ophthalmol; 2004 Feb; 88(2):199-203. PubMed ID: 14736774
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Short-term effect of latanoprost and timolol eye drops on tear fluid and the ocular surface in patients with primary open-angle glaucoma and ocular hypertension.
    Thygesen J; Aaen K; Theodorsen F; Kessing SV; Prause JU
    Acta Ophthalmol Scand; 2000 Feb; 78(1):37-44. PubMed ID: 10726786
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical dose-regimen studies with latanoprost, a new ocular hypotensive PGF2 alpha analogue.
    Diestelhorst M; Krieglstein GK; Lusky M; Nagasubramanian S
    Surv Ophthalmol; 1997 Feb; 41 Suppl 2():S77-81. PubMed ID: 9154280
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A phase 2, randomized, dose-response trial of taprenepag isopropyl (PF-04217329) versus latanoprost 0.005% in open-angle glaucoma and ocular hypertension.
    Schachar RA; Raber S; Courtney R; Zhang M
    Curr Eye Res; 2011 Sep; 36(9):809-17. PubMed ID: 21851167
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Additive efficacy of unoprostone isopropyl 0.12% (rescula) to latanoprost 0.005%.
    Eisenberg DL
    Am J Ophthalmol; 2001 Sep; 132(3):448-9. PubMed ID: 11554383
    [No Abstract]   [Full Text] [Related]  

  • 33. Additive efficacy of unoprostone isopropyl 0.12% (rescula) to latanoprost 0.005%.
    Alward WL
    Am J Ophthalmol; 2001 Sep; 132(3):449-51. PubMed ID: 11554384
    [No Abstract]   [Full Text] [Related]  

  • 34. The Efficacy of a Latanoprost/Timolol Fixed Combination Versus Latanoprost and Timolol Gel-forming Solution Unfixed Combination on Daytime Intraocular Pressure.
    Özyol E; Özyol P
    J Glaucoma; 2016 Feb; 25(2):135-9. PubMed ID: 25264990
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of 24-hour intraocular pressure reduction with two dosing regimens of latanoprost and timolol maleate in patients with primary open-angle glaucoma.
    Konstas AG; Maltezos AC; Gandi S; Hudgins AC; Stewart WC
    Am J Ophthalmol; 1999 Jul; 128(1):15-20. PubMed ID: 10482089
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Randomized parallel group study of 0.0015% tafluprost ophthalmic solution in patients with primary open-angle glaucoma or ocular hypertension (comparison with 0.005% latanoprost ophthalmic solution)].
    Ge J; Li X; Sun X; He X; Zhang H
    Zhonghua Yan Ke Za Zhi; 2015 Feb; 51(2):95-102. PubMed ID: 25907999
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The influence of diclofenac ophthalmic solution on the intraocular pressure-lowering effect of topical 0.5% timolol and 0.005% latanoprost in primary open-angle glaucoma patients.
    Costagliola C; Parmeggiani F; Antinozzi PP; Caccavale A; Cotticelli L; Sebastiani A
    Exp Eye Res; 2005 Nov; 81(5):610-5. PubMed ID: 15949795
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of brimonidine with latanoprost in the adjunctive treatment of glaucoma. ALPHAGAN/XALATAN Study Group.
    Simmons ST; Samuelson TW
    Clin Ther; 2000 Apr; 22(4):388-99. PubMed ID: 10823361
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Latanoprost versus combined therapy with timolol plus dorzolamide: IOP-lowering effect in open-angle glaucoma.
    Polo V; Larrosa JM; Gomez ML; Pablo L; Honrubia FM
    Acta Ophthalmol Scand; 2001 Feb; 79(1):6-9. PubMed ID: 11167277
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A randomized double-masked crossover study comparing latanoprost 0.005% with unoprostone 0.12% in patients with primary open-angle glaucoma and ocular hypertension.
    Aung T; Chew PT; Yip CC; Chan YH; See JL; Khng CG; Hoh ST; Ng LH; Lee HM
    Am J Ophthalmol; 2001 May; 131(5):636-42. PubMed ID: 11336940
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.